Cardiovascular Metabolic Disease (CVMD) Strategy

Driving Market Success in the CVMD Landscape

Refine Your CVMD Commercialization Strategy

The cardiovascular and metabolic disease (CVMD) pharmaceutical market is rapidly evolving, driven by rising disease prevalence, breakthrough therapies, and shifting provider & payer dynamics. As cardiovascular disease remains the leading global cause of death and metabolic conditions (e.g., Diabetes) surge in the midst of a highly competitive pharmaceutical landscape, identifying & implementing actionable & innovative market access strategies has never been more necessary to equip patients with the right treatments and ensure brand success.

The Dedham Group helps pharma manufacturers navigate market access complexities, optimize commercialization, and stay ahead of industry shifts. With data-driven insights and strategic execution, we craft go-to-market plans, pricing frameworks, and salesforce strategies to drive success.

Schedule a Meeting

Our Tailored Services for Success

Value & Access Strategy

Develop a comprehensive plan to ensure optimal patient access, reimbursement, and affordability while maximizing brand value.

Therapy Access
Optimization
Identify and address key payer barriers through targeted value proposition & engagement tactics to support favorable access.

Hospital & Provider Landscape
Assessment (Inpatient & Outpatient):
Analyze the inpatient & outpatient treatment ecosystem to understand formulary dynamics, provider decision-making, and institutional access barriers.

Loss of Exclusivity &
Generic Defense Strategy:
Leverage historical analog trends and address key customer needs through effective strategies to support favorable brand economics & value story.

Economic Optimization

Align pricing & contracting levers to drive favorable customer perceptions & access for patients.

Pricing Sensitivity
& Strategy:
Evaluate key customer & site of care economic sensitivity to understand key pricing thresholds that will inform an optimal launch & post-launch pricing strategy approach

Channel Contracting
Optimization:
Assess opportunities across key payer & provider channels to implement contracting that will support favorable stakeholder economics and overall brand value perceptions & access.

Brand Forecast Modeling &
Market Development Needs:
Develop robust forecast modeling that accounts for market evolution, competitive dynamics, and unmet needs as well as identify opportunities to accelerate therapy market readiness

Post-Launch Innovation

Identify and leverage new opportunities to enhance access, adoption, and engagement post-launch.

Access Vendor
Shark-Tank Workshop:
Conduct a structured evaluation process where innovative access solutions are vetted and prioritized with key access stakeholder insights for implementation

Emerging 3rd Party Technology
Landscape Assessment:
Assess digital health (e.g., companion & prescription digital therapeutics, PDURs, etc.), tech-enabled solutions (e.g., EMR Data Mining, Precision Health / Medicine) and innovative access channels (e.g., DTC channel activation, telemedicine, etc.) that could enhance patient access, adherence, and provider engagement.

Tx Journey Assessment &
Strategic Opportunities:
Map the treatment journey to uncover pain points and opportunities for interventions that improve patient outcomes and access.

We Provide:

Proven Expertise Shaping Winning Strategies for Chronic Disease Therapies

Dedham brings extensive access and commercial strategy expertise across 15+ therapeutic areas, 20+ disease therapy assets, and 10+ manufacturing partners.